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Matrix metalloproteases (MMPs) are proteolytic enzymes secreted by cardiac 
fibroblasts. Altered expression of MMPs plays an important role in congestive heart 
failure and other cardiovascular diseases 1•2• Emerging evidence has led us to consider the 
role of phosphatidylinositol 4-kinase (Ptdlns 4-kinase) in regulating MMP secretion in 
cardiac fibroblast cells3-7 . Ptdlns 4-kinase is a lipid kinase involved in various cellular 
processes including protein secretion. This project was designed to test the hypothesis 
that Ptdlns 4-kinase controls MMP secretion. Techniques such as cardiac cell culture, 
transfection, and in-gel zymography were used for this experiment. Results demonstrated 
that Ptdlns 4-kinase regulates MMP secretion. This research will provide insights in 
revealing molecular details of congestive heart failure and will contribute to the 
development of strategies against cardiovascular diseases. 
Abbreviations used: 
APMA - 4-aminophenyl mercuric acetate 
CVD - cardiovascular disease 
ECM - extracellular matrix 
GFP - green fluorescent protein 
HBSS - Hanks buffered saline solution 
MMP - matrix metalloprotease 
Ptdlns - phosphatidylinositol 
Ptdlns 4-kinase - phosphatidylinositol 4-kinase 
Ptdlns-4P - phosphatidylinositol 4-phosphate 
Ptdlns ( 4,5)P2 - phosphatidylinositol-4,5-bisphosphate 
SOS - sodium dodecyl sulfate 
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Introduction 
Since 1900, cardiovascular disease (CVD) has been the leading cause of death in 
the United States except in 1918. In a 2006 update, the American Heart Association 
estimated that more than 71,300,000 Americans have one or more forms of CVD. In 
particular, five million Americans are affected by one type of CVD called congestive 
heart failure8• Therefore, understanding the development of cardiovascular diseases at 
the molecular and cellular level was the motive for this study. By understanding the 
events that lead to cardiovascular diseases, we can develop specific interventions and 
treatments that could slow or reverse this process. 
An area of growing research is the association of heart extracellular matrix (ECM) 
with congestive heart failure. The extracellular matrix consists of complex network of 
proteins and polysaccharides that forms a dynamic meshwork and occupies a significant 
portion of the extracellular space in mammalian tissues. This matrix is involved in many 
cellular functions including structural support to tissues and intercellular communication. 
The normal heart ECM is predominately composed of collagen polymers which serve as 
major contributors to structural integrity of tissues9. 
The cardiac fibroblast cells are mainly responsible for the synthesis of ECM 
collagen. In addition, fibroblasts regulate ECM collagen through the secretion of 
proteolytic enzymes called matrix metalloproteases (MMPs). These enzymes are 
constitutively expressed and play a critical role in controlling the composition and form 
of the ECM. However, improper MMP levels have been associated with several 
cardiovascular diseases. Previous studies have shown that serum MMP levels are 
significantly elevated in patients with congestive heart failure 1• Further, increased MMP 
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activity is also associated with cardiomyopathy and contractile dysfunction 2. Hence, the 
goal of this research is to determine the underlying mechanisms that regulate MMP 
secretion. 
In this research project, the control of MMP secretion by phosphatidylinositol 4-
kinase (Ptdlns 4-kinase) was examined. Ptdlns 4-kinase is a lipid kinase that regulates 
numerous cellular processes including vesicular transport, signal transduction, and 
cytoskeleton remodeling 10• Its activity is primarily membrane associated and localized to 
the nuclear envelope, endoplasmic reticulum, Golgi, lysosome, and plasma membrane 1°-
12. Ptdins 4-kinases function by converting phosphatidylinositol (Ptdlns) into 
phosphatidylinositol 4-phosphate (Ptdlns-4P). Ptdlns-4P can directly interact with target 
proteins or be converted to phosphatidylinositol-4,5-bisphosphate (Ptdins( 4,5)P 2). 
Ptdlns( 4,5)P 2 is commonly known as a signaling molecule and a substrate for 
phospholipase C to produce inositol 1,4,5-trisphosphate and diacylglycerol. 
Because of its tractable nature, the yeast Saccharomyces cerevisiae has proven to 
be a useful organism to study secretory protein transport. In addition, the mechanism of 
protein secretion in yeast is generally conserved in mammalian cells 13• In 1999, Hama 
and colleagues demonstrated that yeast Ptdlns 4-kinase is involved in Golgi-to-plasma 
membrane vesicular transport 3-5. In addition, it has been shown that Ptdins 4-kinases 
have an important role in protein secretion in higher eukaryotes 6. 
A previous work by Edgar Lee demonstrated that Wortmannin, a known inhibitor 
of Ptdlns 4-kinase, decreased MMP secretion in ordinary fibroblast cells 7• This 
preliminary study suggested that Ptdlns 4-kinase may play a significant role in cardiac 
fibroblast cells. Therefore, we hypothesized that Ptdlns 4-kinase regulates MMP 
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secretion in cardiac fibroblast cells. To observe the functional role of Ptdlns 4-kinase, 
overexpressed wild type Ptdlns 4-kinase (overexpressed wt) and overexpressed point-
mutated Ptdlns 4-kinase ( overexpressed pm) were constructed. These recombinant genes 
created a dominant negative phenotype effect and allowed us to assess Ptdlns 4-kinase 
activity. If Ptdlns 4-kinase controls MMP secretion, then it provides a potential 
intervention in treating congestive heart failure and other cardiovascular diseases. 
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Materials and Methods 
Ptdlns 4-kinase dominant negative alleles 
The dominant negative alleles were created using a S. cerevisiae Ptdlns 4-kinase 
called Pikl. The Pikl gene encodes for a hydrophilic protein (1066 amino acids) that is a 
homo log of the mammalian Ptdlns 4-kinase. The other types of Ptdlns 4-kinase in yeast 
are Stt4p, which has an unknown role in secretion, and LSB6, which does not seem to 
have an essential role 14• The catalytic domain of Pikl was subjected to PCR mutagenesis 
to generate a point mutation and cause it to be inactive. Mutated gene sequence was 
amplified using PCR and was inserted into a bicistronic mammalian expression vector 
(pIRES vector, Clontech) containing green fluorescent protein (GFP). A simultaneous 
expression of both the gene of interest and GFP is achieved and this allowed us to rapidly 
select transfected cells. The recombinant plasmids were digested and run using agarose 
gel electrophoresis to verify that the gene encoding Ptdlns 4-kinase was integrated with 
the vector. Plasmids were amplified using E. coli DH5a and were purified by 
precipitation with polyethylene glycol. 
Cardiac Cell Culture 
One to two days old mice were anesthetized on ice and killed by decapitation. 
Hearts were isolated and the ventricular tissues were digested in 0.25% trypsin in Hanks 
buffered saline solution (HBSS) for 10-15 minutes and were incubated with shaking at 3 7 
0c. For every 5 minutes, contents were forcefully shaken to assist further breakdown of 
the remaining fragments into singly dispersed cells. Contents were poured through a 
sterile funnel-fitted tube with gauze that was initially pre-wetted with 5 mL of serum 
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supplemented medium (90% Dulbecco's Modified Eagle's Medium (DMEM), 10% Fetal 
Bovine Serum). Cells were centrifuged at 1,000 rpm for 10 minutes and were 
resuspended using serum supplemented medium. After 60 minutes at 37 °c, the non-
adherent myocytes were aspirated and a new medium containing 500 ug/ml penicillin and 
streptomyocin was added to the flask. The adherent cells were predominately fibroblasts 
and were cultured at 37 °c in a CO2 incubator until confluency (5-7 days) and passaged 
using standard trypsin-EDT A release. 
Transfection 
One day before transfection, 2-8 x 105 cells were plated in a 6-well plate 
containing growth medium without antibiotics. When cells are 80-90% confluent, they 
were transfected using Lipofectamine from Invitrogen. For each transfection sample, 
DNA and Lipofectamine were mixed and incubated for 20 minutes at room temperature 
to create DNA-Lipofectamine complexes. These complexes were added to each well 
containing cells and medium. Cells were incubated at 37 °c in a CO2 incubator for 24-
48 hours. After transfection, GFP expression was monitored using Bio Rad 1024 laser 
scanning confocal microscope. 
In-gel Zymography 
Cells were starved with serum-free media for 4-6 hours before collecting the 
media for secreted MMPs. Cells were then collected by scraping and were lysed using a 
vortex to determine retained MMPs in the cells. Equal volume samples were 
concentrated in Microcon Centrifugal Filter Devices, YM-10 (Millipore Corporation, 
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Bedford, MA 01730) and sodium dodecyl sulfate (SDS) sample buffer was added. In-gel 
zymography was used to detect MMP activities and measure MMP levels. Zymogram 
gels were prepared with 12% resolving or separating gel [Gelatin Type A, H20, 30% 
acrylamide mix, 1.5 M Tris (pH 8.8), 10% SDS, 10% ammonium persulfate, TEMED] 
and 5% stacking gel [H20, 30% acrylamide mix, 1.0 M Tris (pH 6.8), 10% SDS, 10% 
ammonium persulfate, TEMED]. Samples were activated using l0mM of 4-aminophenyl 
mercuric acetate (APMA) in 0.1 M NaOH for 2 hours in an incubator at 37 °c. Samples 
were loaded and run at 120 mV (small gels) in Ix SDS Running Buffer. Gels were 
removed from glass plates and soaked for 45 minutes in 2.5% Triton X-100 on a shaker. 
Gels were incubated in digesting solution [IM Tris-HCl (pH 8), 1 M CaC'2, 1 mM ZnC'2, 
H20] for 24 hours at 37 °c. After incubation, gels were stained with Coomassie Blue for 
about 15-30 minutes and destained with destaining solution [ 40% methanol, IO % acetic 
acid, H20] until the bands of lysis became clear. 
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Results 
GFP expression by cardiac fibroblast cells was observed using a confocal 
microscope. Transfection efficiency using Lipofectamine varied from 30-50% on all the 






Figure 1. GFP expression in cardiac fibroblast cells. Fibroblast cells were transfected 
with either an empty vector (left), a vector containing an overexpressed wt (middle), or a 
vector containing an overexpressed pm (right). 
MMP activities were observed using an in-gel zymography. Media samples were 
collected after starving the cells with serum-free media to determine levels of secreted 
MMPs. Additionally, the cells were collected to assess levels of retained MMPs inside 
the cells. Control media and control cell lysate samples showed a slight MMP activity at 
~ 55 kDa, while both media samples of overexpressed wt and overexpressed pm had no 
MMP activity. In contrast, cell lysates of overexpressed wt and overexpressed pm 
demonstrated MMP activities at ~55 kDa. Additional MMP activities were detected on 
all cell lysate samples at ~22 kDa (Figure 2). A reasonable interpretation of these results 
is that an MMP activity at ~55 kDa represents MMP13 and MMP activity at ~22 kDa 
represents MMP 12. MMP 13 is a member of the collagenase family and is capable of 
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degrading the fibrillar collagens of type I, II, III, and V. MMP12 is also known as 


























Figure 2. In-gel zymography showing MMP activities. The arrows point to white 
bands which indicate MMP activities while the dark bands represent other types of 
protein. The white bands around 40 kDa are background noises caused by the gel 
chamber. Media samples (Control, overexpressed wt, overexpressed pm) represent 
secreted MMPs while cell lysate samples (Control, overexpressed wt, overexpressed pm) 
represent MMPs retained in the cells. 
Low levels ofMMPs were detected on the gel due to the addition of SOS sample 
buffer containing ~-mercaptoethanol in media and cell lysate samples. The ~-
mercaptoethanol is a reducing agent that severely denatures the MMP conformation 
which consequently prevents the MMP from refolding and becoming active after running 
the gel. As a result, MMP activities were either reduced or prevented from occurring. 
Conclusions 
Most phosphoinositide kinases are considered to be heterodimers containing both 
a catalytic and a regulatory protein subunits 12• Previous reports have demonstrated that 
overexpression of an inactive version of a catalytic protein subunit of a phosphoinositide 
kinase created a dominant negative phenotype effect 16• In this situation, the inactive 
catalytic protein subunits compete with wild type catalytic protein subunits. 
Consequently, this will decrease the overall phosphoinositide kinase activity. In a similar 
condition, overexpressing a wild type version of Ptdlns 4-kinase creates an analogous 
effect with the dominant negative phenotype. It is unknown how this occurs, but it is 
suggested that forced overexpression of Ptdlns 4-kinase in yeast and mammalian cells 
creates an imbalance in the membrane trafficking system and causes the Golgi to 
scatter 14. Therefore, with the disruption of membrane trafficking, it is presumed that 
MMP secretion is hindered. 
Our results confirmed that Ptdlns 4-kinase regulates MMP secretion. As shown 
in Figure 2, the absence of MMP13 secretion in media samples for both the 
overexpressed wt and overexpressed pm indicated that MMP13 was not secreted outside 
the cell. Instead, MMP13 for overexpressed wt and pm were kept inside the cell. 
Therefore, we conclude that Ptdins 4-kinase activity is involved in Golgi-to-plasma 
membrane vesicular transport. Further, we conclude that when Ptdins 4-kinase activity is 
decreased or membrane trafficking is disrupted, MMPl 3 secretion decreases 
correspondingly. To confirm if overexpression of Ptdins 4-kinase scatters the Golgi in 
mammalian cells, Bodipy TR conjugated ceramide (Golgi stain) will be used to observe 
any changes in the Golgi and to check for vesiculation. Contrary to the results of 
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MMP13, MMP12 did not display a similar pattern; they were all seen in cell lysate 
samples. Since MMPl 2 is associated with macrophages, perhaps high concentration of 
macrophages existed in the cell culture. 
In 1998, Tyagi discovered that high levels of specific MMPs (MMPl, MMP2, 
MMP9) were found under heart failure conditions
2
• This led us to predict that MMPI, 
MMP2, and MMP9 have an essential role in remodeling the ECM of the heart and will be 
highly secreted in mouse cardiac cells. However, our results indicate that MMP13 may 
play an important role in cardiac cell function and ultimately in cardiovascular diseases. 
A replication of this experiment will be completed to confirm our results. It is imperative 
that we use SOS sample buffer without the ~-mercaptoethanol on all samples in order to 
enhance the detection of MMP activities. Quantitative analysis of MMPs will also be 
completed to determine the expression levels of MMPs. 
This study will provide a greater understanding on the role of Ptdlns 4-kinase in 
regulation of MMP secretion. By providing additional insights, this study will contribute 
to the likely development of new drugs fur the treatment of cardiovascular diseases. 
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